Track the 에스바이오메딕스 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 에스바이오메딕스 has logged 28 reports. Market capitalisation: €216.7bn. The latest transaction was disclosed on 16 March 2026 (Other). Among the most active insiders: KANG SAEIL. All data is accessible without an account.
28
Insider Decl.
n/a
Thresholds
n/a
10 ops.
Buy Volume
n/a
13 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,527 of 28,199 companies
24.9
score / 100
Value
25
Quality
25
FCF yld-3.9%
Earn yld-3.7%
EV/EBITDA·
ROE-41%
Gross mgn46%
Net mgn-49%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Listed on the XKRX market, 에스바이오메딕스 is a company focused on the health and pharmaceutical sector. It specializes in developing innovative solutions for the medical field.